InsiderClue
Insiders · Profile

Amado Rafael

See Remarks at Zai Lab · EVP of R&D and CMO at Allogene Therapeutics. Filing since 1 Oct 2020. CIK 0001662119

ZLAB Zai Lab Ltd See Remarks · 14 trades ALLO Allogene Therapeutics, Inc. EVP of R&D and CMO · 9 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ZLAB Zai Lab Ltd
6 Apr 2026
See Remarks
Sold at will
2,739
$56.01K
4.6%
ZLAB Zai Lab Ltd
2 Apr 2026
See Remarks
Sold at will
9,910
$202.06K
14.2%
ZLAB Zai Lab Ltd
13 Mar 2026
See Remarks
Sold at will
2,957
$55.08K
6.2%
ZLAB Zai Lab Ltd
3 Mar 2026
See Remarks
Sold on a plan
10,000
$173.80K
19.1%
ZLAB Zai Lab Ltd
31 Dec 2025
See Remarks
Sold at will
10,787
$188.04K
17.1%
ZLAB Zai Lab Ltd
8 Aug 2025
See Remarks
Sold on a plan
3,000
$105.00K
6.6%
ZLAB Zai Lab Ltd
4 Apr 2025
See Remarks
Sold at will
3,029
$100.28K
6.3%
ZLAB Zai Lab Ltd
2 Apr 2025
See Remarks
Sold at will
7,541
$270.68K
15.0%
ZLAB Zai Lab Ltd
17 Mar 2025
See Remarks
Sold on a plan
3,000
$115.23K
8.9%
ZLAB Zai Lab Ltd
31 Dec 2024
See Remarks
Sold at will
7,583
$199.29K
18.3%
ZLAB Zai Lab Ltd
12 Aug 2024
See Remarks
Sold on a plan
3,115
$50.46K
13.2%
ZLAB Zai Lab Ltd
4 Apr 2024
See Remarks
Sold at will
1,952
$30.59K
7.7%
ZLAB Zai Lab Ltd
15 Mar 2024
See Remarks
Sold on a plan
2,544
$47.98K
11.2%
ZLAB Zai Lab Ltd
2 Jan 2024
See Remarks
Sold at will
19,363
$509.17K
46.1%
ALLO Allogene Therapeutics, Inc.
2 Aug 2022
EVP of R&D and CMO
Sold, plan not stated
2,000
$23.94K
0.4%
ALLO Allogene Therapeutics, Inc.
5 Jul 2022
EVP of R&D and CMO
Sold, plan not stated
2,000
$22.88K
0.4%
ALLO Allogene Therapeutics, Inc.
21 Jun 2022
EVP of R&D and CMO
Sold, plan not stated
2,000
$22.36K
0.4%
ALLO Allogene Therapeutics, Inc.
19 May 2022
EVP of R&D and CMO
Sold, plan not stated
11,500
$85.09K
2.1%
ALLO Allogene Therapeutics, Inc.
15 Mar 2022
EVP of R&D and CMO
Sold, plan not stated
5,169
$39.85K
1.6%
ALLO Allogene Therapeutics, Inc.
1 Oct 2021
EVP of R&D and CMO
Sold, plan not stated
11,507
$280.19K
3.4%
ALLO Allogene Therapeutics, Inc.
15 Mar 2021
EVP of R&D and CMO
Sold, plan not stated
2,798
$106.47K
2.5%
ALLO Allogene Therapeutics, Inc.
7 Oct 2020
EVP of R&D and CMO
Sold, plan not stated
16,538
$651.51K
12.9%
ALLO Allogene Therapeutics, Inc.
1 Oct 2020
EVP of R&D and CMO
Sold, plan not stated
9,752
$354.66K
7.1%
23 decisions on file.